Reply to W.A.A. Tjalma and J.S. Grossman

J Clin Oncol. 2015 Mar 10;33(8):966. doi: 10.1200/JCO.2014.59.6205. Epub 2015 Feb 9.

Authors

Bradley J Monk¹, David S Miller², Krishnansu S Tewari³

Affiliations

¹ Division of Gynecologic Oncology, University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ bradley.monk@chw.edu.
² Division of Gynecologic Oncology, UT Southwestern Medical Center at Dallas, Dallas, TX.
³ Division of Gynecologic Oncology, University of California, Irvine Medical Center, Orange, CA.

PMID: 25667286
DOI: 10.1200/JCO.2014.59.6205

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Neoplasm Recurrence, Local / diagnosis*
Uterine Cervical Neoplasms / diagnosis*
Uterine Cervical Neoplasms / drug therapy*
Uterine Cervical Neoplasms / therapy*